Cargando…
DNA methylation enzyme inhibitor RG108 suppresses the radioresistance of esophageal cancer
Esophageal cancer (EC) is the eighth most common highly aggressive cancer worldwide. The purpose of this study was to investigate the effect of the DNA methyltransferase inhibitor RG108 on the radiosensitivity of EC cells. MTT and clonogenic assays were performed to assess the effect of RG108 on the...
Autores principales: | Ou, Yao, Zhang, Quan, Tang, Yiting, Lu, Zhonghua, Lu, Xujing, Zhou, Xifa, Liu, Changmin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5802040/ https://www.ncbi.nlm.nih.gov/pubmed/29328411 http://dx.doi.org/10.3892/or.2018.6210 |
Ejemplares similares
-
The DNA methylation inhibitor RG108 protects against noise-induced hearing loss
por: Zheng, Zhiwei, et al.
Publicado: (2021) -
mRNA and methylation profiling of radioresistant esophageal cancer cells: the involvement of Sall2 in acquired aggressive phenotypes
por: Luo, Judong, et al.
Publicado: (2017) -
REV7 confers radioresistance of esophagus squamous cell carcinoma by recruiting PRDX2
por: Gu, Cheng, et al.
Publicado: (2019) -
SOX17-mediated MALAT1-miR-199a-HIF1α axis confers sensitivity in esophageal squamous cell carcinoma cells to radiotherapy
por: Yun, Yifei, et al.
Publicado: (2022) -
Expression of YY1 correlates with progression and metastasis in esophageal squamous cell carcinomas
por: Luo, Judong, et al.
Publicado: (2014)